Antiretroviral Therapies for Human Immunodeficiency Virus and Liver Disease: Challenges and opportunities
Julio C. Abarca, Leonor Huerta, Nora A. Fierro
Annals of Hepatology · 2020
doi:10.1016/j.aohep.2020.02.004 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Summary: The post antiretroviral therapy (ART) era for human immunodeficiency virus (HIV) infection resulted in a dramatically increased proportion of deaths attributed to liver-related causes in patients with HIV treated with ART. Additionally, as patients become older as a result of effective ART, liver-related conditions and application of safe therapies are now major concerns in the setting of HIV infection.
Abstract licence: CC BY-NC-ND
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.